Fosdenopterin
Small Molecule
Overview
Fosdenopterin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2338675).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Fosdenopterin expires 9 Apr 2029 and exclusivity 26 Feb 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (1R,10R,12S,17R)-5-amino-11,11,14-trihydroxy-14-oxo-13,15,18-trioxa-2,4,6,9-tetraza-14lambda5-phosphatetracyclo[8.8.0.03,8.012,17]octadeca-3(8),5-dien-7-one
- Canonical SMILES
- C1[C@@H]2[C@@H](C([C@H]3[C@@H](O2)NC4=C(N3)C(=O)N=C(N4)N)(O)O)OP(=O)(O1)O
- InChIKey
- CZAKJJUNKNPTTO-AJFJRRQVSA-N
Verified Supplier Partner
Do you supply Fosdenopterin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.